MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients

HORÁK, J., DOLNÍKOVÁ, A., CUMAOGULLARI, O., ČUMOVÁ, A., NAVVABI, N., VODIČKOVÁ, L., LEVÝ, M., SCHNEIDEROVÁ, M., LIŠKA, V., ANDĚRA, L., VODIČKA, P., OPATTOVÁ, A. MiR-140 leads to MRE11 downregulation and ameliorates oxaliplatin treatment and therapy response in colorectal cancer patients. Frontiers in Oncology. 2022, 12(oct), 959407. ISSN 2234-943X. E-ISSN 2234-943X. Dostupné z: doi: 10.3389/fonc.2022.959407.